✦ LIBER ✦

P.4.a.001 Quality of life outcomes in obsessive-compulsive disorder: relationship to treatment response and symptom relapse

✍ Scribed by N.A. Fineberg; D.J. Stein; M. Legault; F. Marteau; E. Hollander

Book ID: 118597438
Publisher: Elsevier Science
Year: 2010
Tongue: English
Weight: 62 KB
Volume: 20
Category: Article
ISSN: 0924-977X
DOI: 10.1016/s0924-977x(10)70778-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P.4.a.004 The use of psychopharmacologic

P.4.a.004 The use of psychopharmacological agents in a sample of patients with obsessive-compulsive disorder and their relationship to symptoms

✍ V. Brakoulias; V. Starcevic; P. Sammut; D. Berle; D. Milicevic; K. Moses; A. Han 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 76 KB

The Myelofibrosis Symptom Assessment For

The Myelofibrosis Symptom Assessment Form (MFSAF): An evidence-based brief inventory to measure quality of life and symptomatic response to treatment in myelofibrosis

✍ Ruben A. Mesa; Susan Schwager; Deepti Radia; Andrea Cheville; Kebede Hussein; Jo 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 619 KB

Quality of life (QoL) in patients with myelofibrosis (MF) is severely compromised by severe constitutional symptoms (i.e. fatigue, night sweats, fever, weight loss), pruritus, and symptoms from frequently massive hepatosplenomegaly. Given that no current instrument of patient reported outcomes (PRO)